Atlas Trials

Invion, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Invion, Inc.

RecordFirmDate
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction (NCT01825122)Invion, Inc.2014-03-01
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. (NCT01838694)Invion, Inc.2013-07-01
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma (NCT01804218)Invion, Inc.2013-03-01
Oral Nadolol for the Treatment of Adults With Mild Asthma (NCT00670267)Invion, Inc.2007-01-01

Track Invion, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.